Cargando…
Profiling novel pharmacology of receptor complexes using Receptor-HIT
Many receptors are able to undergo heteromerisation, leading to the formation of receptor complexes that may have pharmacological profiles distinct from those of the individual receptors. As a consequence of this, receptor heteromers can be classed as new drug targets, with the potential for achievi...
Autores principales: | Johnstone, Elizabeth K.M., Pfleger, Kevin D.G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421044/ https://www.ncbi.nlm.nih.gov/pubmed/34436548 http://dx.doi.org/10.1042/BST20201110 |
Ejemplares similares
-
Novel Pharmacology Following Heteromerization of the Angiotensin II Type 2 Receptor and the Bradykinin Type 2 Receptor
por: Johnstone, Elizabeth K. M., et al.
Publicado: (2022) -
Receptor-Heteromer Investigation Technology and its application using BRET
por: Johnstone, Elizabeth K. M., et al.
Publicado: (2012) -
THU596 Heteromerization Of The Angiotensin II Type 1 Receptor And The Bradykinin Type 2 Receptor
por: Johnstone, Elizabeth K M, et al.
Publicado: (2023) -
Molecular determinants of orexin receptor-arrestinubiquitin complex formation
por: Jaeger, Werner C, et al.
Publicado: (2014) -
Temporal Profiling of Orexin Receptor-Arrestin-Ubiquitin Complexes Reveals Differences between Receptor Subtypes
por: Dalrymple, Matthew B., et al.
Publicado: (2011)